Skip to main content

UTAH MEDICAL PRODUCTS INC

Data quality: 100%
UTMD
Nasdaq Manufacturing Measuring & Analyzing Instruments
$65.47
▲ $0.94 (1.45%)
Mkt Cap: 209.73 M
Price
$65.47
Mkt Cap
209.73 M
Day Range
$63.36 — $65.47
52-Week Range
$51.26 — $68.71
Volume
7,162
Open $63.40
50D / 200D Avg
$63.99
2.31% above
50D / 200D Avg
$59.86
9.36% above

Quick Summary

Key Takeaways

Revenue declined -5.86% annually over 5 years
Earnings declined -18.65% over the past year
Net margin of 29.30% shows strong profitability
Generating 14.32 M in free cash flow
Cash machine — converts 126.89% of earnings into free cash flow
Capital efficient — spends only 0.96% of revenue on capex

Growth

Revenue Growth (5Y)
-5.86%
Below sector avg (1.82%)
Revenue (1Y)-5.83%
Earnings (1Y)-18.65%
FCF Growth (3Y)-18.65%

Quality

Return on Equity
9.57%
Above sector avg (-53.41%)
ROIC7.68%
Net Margin29.30%
Op. Margin29.60%

Safety

Debt / Equity
N/A
Current Ratio32.06
Interest CoverageN/A

Valuation

PE (TTM)
18.58
Above sector avg (-1.48)
P/B Ratio1.77
EV/EBITDA11.00
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 18.6 -1.5
P/B 1.8 1.6
ROE % 9.6 -53.4
Net Margin % 29.3 -41.5
Rev Growth 5Y % -5.9 1.8
D/E 0.3

ETFs Holding This Stock

DEEP logo DEEP Acquirers Small and Micro Deep Value ETF
1.04% weight
SQLV logo SQLV Royce Quant Small-Cap Quality Value ETF
0.20% weight
MXTFX MXTFX
0.07% weight
MXLSX MXLSX
0.07% weight
DES logo DES WisdomTree U.S. SmallCap Dividend Fund
0.06% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.02% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight
AVUV logo AVUV Avantis U.S. Small Cap Value ETF
0.00% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) -5.83% Revenue Growth (3Y) -12.42%
Earnings Growth (1Y) -18.65% Earnings Growth (3Y) -17.63%
Revenue Growth (5Y) -5.86% Earnings Growth (5Y) -6.53%
Profitability
Revenue (TTM) 38.52 M Net Income (TTM) 11.29 M
ROE 9.57% ROA 9.30%
Gross Margin 57.12% Operating Margin 29.60%
Net Margin 29.30% Free Cash Flow (TTM) 14.32 M
ROIC 7.68% FCF Growth (3Y) -18.65%
Safety
Debt / Equity N/A Current Ratio 32.06
Interest Coverage N/A Asset Turnover 0.32
Working Capital 93.52 M Tangible Book Value 102.81 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 18.58 Forward P/E N/A
P/B Ratio 1.77 P/S Ratio 5.44
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 11.00 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 6.83%
Market Cap 209.73 M Enterprise Value 125.46 M
Per Share
EPS (Diluted TTM) 3.48 Revenue / Share 12.02
FCF / Share 4.47 OCF / Share 4.59
EPS CAGR (1Y) -12.12% EPS CAGR (5Y) -3.66%
EPS CAGR (10Y) 0.87%
Efficiency
CapEx / Revenue 0.96% FCF Conversion 126.89%
SBC-Adj. FCF 14.01 M Growth Momentum 0.03

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 38.52 M 40.90 M 50.22 M 52.28 M 49.05 M
Net Income 11.29 M 13.87 M 16.64 M 16.47 M 14.79 M
EPS (Diluted) 3.48 3.96 4.57 4.52 4.04
Gross Profit 22.00 M 24.14 M 30.04 M 32.20 M 30.92 M
Operating Income 11.40 M 13.59 M 16.78 M 19.79 M 18.88 M
EBITDA
R&D Expenses 668,000.0 813,000.0 560,000.0 493,000.0 526,000.0
SG&A Expenses
D&A
Interest Expense
Income Tax 2.82 M 2.93 M 3.45 M 4.19 M 4.27 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 122.54 M 122.54 M 135.46 M 123.87 M 115.64 M
Total Liabilities 3.27 M 5.11 M 7.15 M 9.62 M 8.50 M
Shareholders' Equity 119.27 M 117.43 M 128.31 M 114.25 M 107.14 M
Total Debt 0.0 0.0 0.0 0.0 0.0
Cash & Equivalents 85.76 M 82.98 M 92.87 M 75.05 M 60.97 M
Current Assets 97.74 M 96.33 M 106.27 M 89.92 M 73.16 M
Current Liabilities 2.60 M 3.76 M 4.71 M 5.96 M 3.75 M